<DOC>
	<DOC>NCT00501878</DOC>
	<brief_summary>To compare the clinical efficacy and systemic side effects between 2.5% and 10% phenylephrine for mydriasis in diabetic patient with darkly pigmented irides.</brief_summary>
	<brief_title>2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides</brief_title>
	<detailed_description>One hundred patients with diabetes from Srinagarind Hospital Eye Clinic were enrolled and randomized into two groups by block randomization. In group I (50 patients), 1% tropicamide combined with 2.5% phenylephrine were administered to dilate pupil whereas 1% tropicamide combined with 10% phenylephrine were used in Group II (50 patients). Pupil diameter, blood pressure and heart rate were measured before and after eye drop instillations.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Mydriasis</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<criteria>diabetic patients history of intraocular surgery or laser treatment, any ocular diseases that might affect pupil size such as glaucoma,uveitis,Horner's syndrome, Adies' pupil, history of allergy to any drug used, and hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>phenylephrine</keyword>
	<keyword>mydriasis</keyword>
	<keyword>diabetes mellitus</keyword>
</DOC>